Director Eric Sachetta buys Sensus Healthcare (SRTS) shares in open market

Rhea-AI Filing Summary

Sensus Healthcare, Inc. director Eric Sachetta reported buying additional company shares in the open market. On this Form 4, he acquired 2,000 shares of common stock at an average price of $3.81 per share. After this transaction, his directly owned holdings increased to 142,113 common shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sachetta Eric

(Last) (First) (Middle)

851 BROKEN SOUND PARKWAY NW #215

(Street)

BOCA RATON FL 33487

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sensus Healthcare, Inc. [ SRTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/24/2026		P		2,000	A	$3.81(1)	142,113	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the average price per share.

	/s/ Eric Sachetta	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Sensus Healthcare (SRTS) report on this Form 4?

The filing reports that director Eric Sachetta purchased 2,000 shares of Sensus Healthcare common stock. The transaction was an open-market buy, indicating he increased his personal share ownership in the company through a direct purchase.

At what price did the Sensus Healthcare (SRTS) director buy shares?

Eric Sachetta bought the 2,000 Sensus Healthcare common shares at an average price of $3.81 per share. A footnote explains this figure represents the average price per share for the reported open-market purchase transaction.

How many Sensus Healthcare (SRTS) shares does the director own after this transaction?

Following the reported purchase, director Eric Sachetta directly owns 142,113 shares of Sensus Healthcare common stock. This post-transaction total reflects the addition of the 2,000 shares acquired in the open-market transaction disclosed in the Form 4.

Was the Sensus Healthcare (SRTS) insider transaction a buy or a sell?

The transaction was a buy. The Form 4 identifies it as an open-market purchase of 2,000 Sensus Healthcare common shares by director Eric Sachetta, using transaction code “P” for purchase and explicitly labeling the direction as a buy.

Who is the insider involved in this Sensus Healthcare (SRTS) Form 4 filing?

The insider is Eric Sachetta, a director of Sensus Healthcare. The Form 4 shows he directly purchased additional common stock, increasing his reported stake to 142,113 shares after completing the open-market transaction.